|
HS Code |
304982 |
| Chemical Name | Vitamin E Tocopheryl Polyethylene Glycol Succinate |
| Common Abbreviation | TPGS |
| Chemical Formula | C33H54O5-(C2H4O)n |
| Molecular Weight | Dependent on PEG chain length |
| Appearance | Waxy solid or viscous liquid |
| Solubility | Water soluble |
| Functional Role | Non-ionic surfactant and solubilizer |
| Origin | Synthetic derivative of natural Vitamin E |
| Cas Number | 9002-96-4 |
| Applications | Drug delivery, pharmaceutical excipient, nutraceuticals |
| Toxicity | Generally regarded as safe (GRAS) |
| Stability | Stable under normal conditions |
| Melting Point | 30-40°C (varies by PEG length) |
| Odor | Mild, characteristic |
| Color | White to off-white |
As an accredited Vitamin E Tocopheryl Polyethylene Glycol Succinate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | The packaging is a 1 kg white HDPE bottle with a secure screw cap, labeled “Vitamin E Tocopheryl Polyethylene Glycol Succinate, USP”. |
| Shipping | Vitamin E Tocopheryl Polyethylene Glycol Succinate should be shipped in tightly sealed containers, protected from moisture, heat, and direct sunlight. It is generally transported as a non-hazardous material. Ensure containers are clearly labeled and handled according to standard chemical shipping regulations to maintain product integrity and safety during transit. |
| Storage | Store Vitamin E Tocopheryl Polyethylene Glycol Succinate in a tightly closed container, in a cool, dry, and well-ventilated area. Protect from light, heat, and moisture. Avoid freezing and keep away from incompatible substances such as strong oxidizers. Store at room temperature, ideally between 15–30°C (59–86°F). Ensure the storage area is clearly labeled and access is restricted to authorized personnel. |
|
Purity 99%: Vitamin E Tocopheryl Polyethylene Glycol Succinate with purity 99% is used in pharmaceutical softgel formulations, where it enhances drug solubilization and bioavailability. Molecular Weight 1500: Vitamin E Tocopheryl Polyethylene Glycol Succinate with molecular weight 1500 is used in intravenous drug delivery systems, where it improves emulsification and rapid dispersion. Viscosity Grade Low: Vitamin E Tocopheryl Polyethylene Glycol Succinate of low viscosity grade is used in oral liquid supplements, where it enables easy processing and uniform distribution. Melting Point 38°C: Vitamin E Tocopheryl Polyethylene Glycol Succinate with a melting point of 38°C is used in topical creams, where it ensures controlled release and skin absorption. Stability Temperature 70°C: Vitamin E Tocopheryl Polyethylene Glycol Succinate stable at 70°C is used in heat-processed nutraceutical blends, where it maintains antioxidant activity during manufacturing. Particle Size 20 Micron: Vitamin E Tocopheryl Polyethylene Glycol Succinate with particle size 20 micron is used in tablet coatings, where it provides smooth texture and uniform coverage. Hydrophilic-Lipophilic Balance (HLB) 13: Vitamin E Tocopheryl Polyethylene Glycol Succinate with HLB of 13 is used in cosmetic emulsions, where it achieves high stability and clear appearance. Residual Solvent <0.5%: Vitamin E Tocopheryl Polyethylene Glycol Succinate with residual solvent less than 0.5% is used in parenteral formulations, where it meets safety standards and regulatory compliance. |
Competitive Vitamin E Tocopheryl Polyethylene Glycol Succinate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: admin@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Vitamin E Tocopheryl Polyethylene Glycol Succinate, often shortened to Vitamin E TPGS, marks an important evolution in our line of functional chemical ingredients. As a manufacturer focused on the unique challenges faced in both pharmaceutical and nutritional applications, we have spent years refining both the chemistry and production methods behind TPGS. While the Vitamin E molecule is familiar as an essential antioxidant, the addition of polyethylene glycol (PEG) succinate extends its value far beyond a simple nutrient. Through direct experience in scaling up TPGS production, we have seen how this ingredient solves real problems in solubility and delivery—areas where traditional Vitamin E forms fall short.
Vitamin E by itself typically suffers from very low water solubility. This limits its use in many formulations, especially where aqueous solubility and bioavailability matter most. Over time, we observed the same pattern with countless active ingredients in our partners’ development labs—water insolubility translating into poor absorption and inconsistent therapeutic effects. With TPGS, we bring a solution developed directly from addressing this gap. By forming an amphiphilic molecule, combining the antioxidant strength of tocopherol with hydrophilic PEG, we see dramatic enhancements in aqueous dispersibility.
Our Vitamin E TPGS production facility runs a continuous process, tightly controlling pegylation and succinylation steps to ensure a reproducible product. Through countless trial batches, we learned the importance of precision during the conjugation step. Too much PEG and the antioxidant properties are diluted; too little and solubilization suffers. We set our PEG average molecular weight in the 1000–1500 Da range, arriving at this figure after testing dozens of alternatives and reviewing stability, flow, and dissolution outcomes from each run. Each batch passes stringent purity, peroxide value, and heavy metal inspections—the reality is that even slight inconsistencies in raw materials can cause downstream headaches for formulators.
One commonly used specification for our TPGS, model TPGS-1000, features a colorless to light yellow waxy appearance, with an HPLC tocopherol content regularly exceeding 25%. Usually, this material remains free-flowing at room temperature if stored properly, and we focus a good share of our QC resources on ensuring minimal batch-to-batch variance. This attention to practical manufacturing details sets apart a real producer from companies simply repackaging bulk imports.
Customers switching over from standard Vitamin E esters—either acetate or succinate—often ask about the differences in function. Having synthesized and analyzed both in the same facility, we see the clear trade-offs in real application. Acetate and succinate esters remain fat-soluble, effective as antioxidants in oil-based systems but nearly useless when a formula must disperse or dissolve in water. In our plant, we ran dissolution tests with both forms next to TPGS under simulated gastric and intestinal environments. Standard esters stuck to the vessel walls or floated as separate phases. TPGS, on the other hand, quickly formed stable micellar emulsions—observable even to the naked eye.
Formulators in the pharmaceutical sector return to TPGS again and again for just this reason. Poorly soluble actives that barely register bioavailability metrics get a second chance when combined with TPGS. We have witnessed improved absorption rates in third-party studies for a variety of molecules, most famously paclitaxel and cyclosporine. The cause is not just improved wetting, but active transport—the PEG chains and succinate backbone interact with intestinal uptake mechanisms. In the dietary supplement field, TPGS provides a practical route for softgel and syrup-based Vitamin E enrichment, avoiding the need for oil-based carriers.
As actual producers, our conversations with product developers reflect the day-to-day impact of switching to TPGS. Customers working with water-dispersible vitamins, pediatric blends, enteral nutrition, and eye drops face the same challenge: classic tocopherol and its simple esters often separate, degrade, or fail to reach target absorption rates. Our engineers run real-world stability studies, using TPGS as the emulsifier and carrier, testing at different pH values and temperatures over periods of months. In most emulsions, we see little to no phase separation and markedly less degradation compared to non-PEGylated analogs.
This translates to less worry about shelf stability in high-humidity climates, less frequent recalls for failed batches, and a more straightforward formulation path. We have heard from formulation scientists who cut their product development time in half by integrating TPGS instead of experimenting with blends of surfactants. This is not theory—it is the accumulation of real testing data and production outcomes observed over thousands of kilograms of product lots.
Years of regulatory compliance work taught us the reality behind excipient acceptance and safety. TPGS has received approval from multiple health authorities as a pharmaceutical excipient and is also listed in several major pharmacopeias. As a manufacturer subject to random international audits, we maintain traceability from the tocopherol-d source to the finished drum, including batch retention samples that we regularly analyze for impurities and degradation products. In practice, this means our clients receive detailed CoAs and impurity profiles up front, with full transparency.
The linking of PEG to Vitamin E introduces additional scrutiny, particularly around possible PEG-derived impurities or residual catalysts. Through in-house purification and targeted catalyst removal, residual heavy metals in our TPGS consistently fall well below the strict limits set by both the US and European authorities. We also routinely partner with contract labs to verify absence of ethylene oxide residues at levels far below international thresholds. Years spent answering auditor questions prepared us to anticipate and solve concerns during pre-approval phases, so our partners can rely on a smooth dossier process.
In active formulation settings, TPGS takes on several roles based on our customers’ specific targets. As a pharmaceutical excipient, it often appears as a solubilizer for Class II/IV APIs under the Biopharmaceutics Classification System, particularly where other solubilizers introduce toxicity or instability. In oral delivery, TPGS supports both softgel and tablet systems—either as a stand-alone solubilizer or as part of a multi-component matrix. Our plant engineers routinely collaborate with R&D teams on optimizing melt flow rates, mixing protocols, and granulation steps to keep TPGS concentrations within safe and effective boundaries.
In topical products, vitamin E TPGS carries both active ingredient and penetration enhancing functions. Over years of feedback, topical formulation houses report improved drug diffusion and less skin irritation than with other solubilizers. Taking the example of ophthalmic drops, standard emulsifiers often introduce discomfort, but TPGS’ mild profile and stability in the eye’s pH range allows for smoother application experiences. Our own sample retention program tracked viscosity drift and color change over long-term storage, demonstrating that finished products containing TPGS fared better than those with alternative surfactants.
In nutrition, demand for water-soluble vitamins is growing, especially for products aimed at children, the elderly, and those facing absorption challenges. We receive weekly inquiries from contract manufacturers seeking to improve the dispersibility and stability of Vitamin E in multivitamin drinks, enteral nutrition solutions, and chewable supplements. Many innovators previously relied on oil-based carriers but faced taste, mouth-feel, and sedimentation complaints from end users. When these producers make the switch to Vitamin E TPGS, feedback often includes better clarity in beverages, greater acceptance among taste panels, and easier powder blending in instant supplement mixes.
Our familiarity with TPGS’s behavior in large-scale food systems means we actively conduct pilot-scale tests, sending test samples straight into our clients’ processing lines for head-to-head performance evaluations. We analyze the distribution of tocopherol equivalents using high-sensitivity assays to ensure both label claim compliance and consistent dosing. The success stories we’ve collected span powdered ready-to-mix drinks, shelf-stable liquid supplements, and fat-reduced mayonnaise and margarine formulas—all benefiting from the amphiphilic character and chemical stability of TPGS, which matches or exceeds conventional esters in shelf-life while surpassing them in solubility.
Manufacturing TPGS at scale brings unique technical hurdles. Our technicians constantly monitor reactor temperature, pH, stirring speed, and raw material purity, because even small deviations can impact overall quality. We run continuous inline monitoring for peroxide levels to prevent oxidative degradation—a recurring issue we solved only after multiple rounds of root-cause analysis. We have learned to schedule fresh tocopherol delivery to align directly with synthesis runs, keeping storage time and exposure to light and oxygen to a minimum.
Every batch we produce receives both in-process and outgoing quality checks, from melting point determination to advanced impurity testing. After learning from customer feedback, we reduced average particle size and adjusted packaging moisture controls, which eliminated clumping and dissolution lag in the final product. These improvements reflect the pragmatic focus that only an actual manufacturer develops after years of meeting evolving customer standards and regulatory expectations.
Over our years of operation, environmental responsibility has become central. By optimizing PEG recycling during the synthesis of TPGS, we cut chemical waste by over 20% relative to historical processes. Our team invested in closed-loop solvent recovery, and we now recover and reuse over 80% of solvents employed throughout pegylation and succinylation stages. Not only does this align with industry sustainability goals, but it also protects supply chain continuity in an era of rising global logistics costs.
The volatility of vitamin E and PEG feedstock markets became very real during global supply disruptions. We counteract this through long-term procurement contracts, in-house purification, and multiple sourcing audits. Our priority remains to keep lead times short and product quality consistent—lessons learned after fielding urgent orders from customers struggling with interrupted ingredient pipelines.
Successful product development in life sciences demands more than a supply of chemical entities—it requires access to production experience, reliable testing, and an understanding of market-driven needs. As direct producers of Vitamin E TPGS, we commit to supporting formulators not only with a dependable ingredient, but also with the data and insight that come from hundreds of collaborative projects. We invest in stability studies across temperature and humidity extremes, develop custom documentation to support new market entries, and maintain open labs for joint troubleshooting.
Our technical advisory team partners closely with clients’ R&D labs, running hands-on trials to optimize dosing, reduce impurity risk, and troubleshoot interface issues in finished products. Through this back-and-forth, we gather data and incorporate feedback, steadily refining both synthesis and quality protocols. As new regulations emerge—from clean-label initiatives to green chemistry mandates—we update both our processes and customer education material, equipping formulators to launch compliant, innovative products leveraging the unique strengths of TPGS.
Experience shows that even high-grade TPGS faces hurdles. Highly sensitive applications such as injectable drugs require extremely tight controls on residual solvents and byproducts, pushing our purification and testing systems to their limits. For solid oral products, powder flow and compressibility can swing based on subtle variations in humidity during storage. We revised our environmental controls and drum-sealing protocols after several large-scale customers reported caking in extended storage. This practical learning loop differentiates a committed manufacturing partner from generic suppliers.
Repeated collaboration with bioequivalence labs taught us about the subtle impacts TPGS may have on both drug and excipient compatibility—some API complexes behave unpredictably, requiring real-time adjustment to PEG chain length or switching antioxidant additives upstream. As regulatory focus intensifies on trace impurities, we continue to upgrade spectrometry and chromatography capability, routinely detecting trace byproducts invisible to less-resourced labs. Our process engineers and quality group collaborate directly to implement corrective actions, keeping pace with the evolving requirements of global brands and their downstream partners.
Across decades, we have witnessed the difference direct manufacturing makes. Integrating all production steps under one roof lets us offer tailored support for every stage, from pilot batches to full-scale commercial runs. As producers, we are able to offer transparency, open dialogue, and a tangible history of traceability for every unit sold. Our operations, product quality, and problem-solving power all build on the lived reality of running reactors, managing supply chains, and meeting shifting demands from both the pharmaceutical and health foods industries.
Vitamin E TPGS, viewed from inside a manufacturer’s operation, is more than a specialty chemical. It represents a pragmatic solution to critical formulation problems—solubility, delivery, stability—encountered time and again across product development. Our work, investments, and daily adaptations keep this ingredient reliable, safe, and innovation-ready, directly supporting the progress of partners throughout the health and wellness sector.